After speaking with call with a physician from Hackensack University Medical Center, one of the early adopters of the company's SP robotic system, Piper Jaffray analyst JP McKim reiterates an Overweight rating on Intuitive Surgical with a $625 price target. Early feedback was largely positive, McKim tells investors in a research note. He says that while SP will be more cannibalistic in urology, it will "open up the door into new specialties like ENT and fuel additional growth to General Surgery." The analyst believes that if SP can get the same clinical outcomes as multiport systems, patients are going to be drawn to its single incision surgery.